What are the differences between mitral regurgitation and aortic regurgitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Key Differences Between Mitral and Aortic Regurgitation

Mitral regurgitation represents a pure volume overload with low-pressure ejection into the left atrium, while aortic regurgitation constitutes a combined pressure and volume overload with high-pressure ejection into the aorta—these fundamental hemodynamic differences drive distinct patterns of ventricular remodeling, tissue characteristics, and clinical outcomes 1.

Hemodynamic Loading Patterns

The critical distinction lies in afterload:

  • Aortic regurgitation: Combined pressure and volume overload where excess blood is ejected against high aortic pressure, resulting in markedly elevated afterload (mean systolic stress 260 ± 41 dynes × 10³/cm²) 2

  • Mitral regurgitation: Nearly pure volume overload where regurgitant blood flows into the low-pressure left atrium, maintaining normal afterload (mean systolic stress 186 ± 34 dynes × 10³/cm²) 2

Both conditions produce comparable preload elevation (end-diastolic stress ~69-81 dynes × 10³/cm² vs 36 in normal subjects), but the afterload difference fundamentally alters ventricular response 2.

Ventricular Remodeling Patterns

Aortic regurgitation produces more pronounced increases in ventricular volume and mass across all degrees of regurgitation severity 3:

  • Eccentric hypertrophy is the dominant pattern (58.3% in ≥moderate AR)
  • Increased wall thickness with proportional chamber enlargement
  • Greater longitudinal dimension expansion
  • Reduced fractional shortening along the long axis 4

Mitral regurgitation demonstrates 3:

  • Normal geometry in 56.7% of cases with ≥moderate regurgitation
  • Myocardial thinning with low mass-to-volume ratio (18.4%)
  • Less pronounced volume and mass increases compared to AR at matched regurgitant volumes
  • Preserved long-axis function 4

Diastolic Function Differences

Pulsed tissue Doppler reveals distinct diastolic patterns 4:

  • AR: Early diastolic filling associated with expansion along the short axis but decreased excursion along the long axis; lower peak early diastolic wall motion velocity and prolonged relaxation time

  • MR: Early diastolic filling associated with expansion along both long and short axes; higher peak early diastolic velocities and shorter relaxation times

Myocardial Tissue Characteristics

Patients with mitral regurgitation demonstrate progressive myocardial damage with increasing regurgitant volume, while aortic regurgitation patients show stable tissue characteristics 3:

  • MR: Higher prevalence of myocardial scarring on late gadolinium enhancement and increased extracellular volume fraction with worsening regurgitation (P < 0.001 for trend)

  • AR: Unchanged myocardial scarring prevalence and extracellular volume across the spectrum of regurgitation severity (P = 0.24 and 0.42)

This suggests MR causes more intrinsic myocardial damage independent of loading conditions.

Systemic Cardiac Output

Systemic forward stroke volume behaves differently 3:

  • AR: Systemic cardiac index remains unchanged across the spectrum of regurgitation severity
  • MR: Systemic cardiac index progressively declines with increasing regurgitant volume

This reflects the different compensatory mechanisms and explains why MR patients may present with more systemic hypoperfusion symptoms.

Contractile Function and Surgical Response

The favorable loading conditions in MR mask contractile dysfunction, while excessive afterload in AR contributes to poor pump performance 2:

  • MR patients: Contractile depression tends to be more severe despite similar ejection performance to AR; the left ventricle is less tolerant of preoperative dysfunction; afterload increases after mitral valve replacement, decreasing ejection performance 1

  • AR patients: Afterload reduction after valve replacement increases ejection performance if it was depressed preoperatively; the ventricle tolerates more preoperative dysfunction with better postoperative recovery 1

Clinical Implications for Timing of Intervention

These pathophysiologic differences mandate different surgical timing strategies 1, 5:

  • Mitral regurgitation: Requires earlier intervention before contractile dysfunction develops, as the ventricle responds poorly to the sudden afterload increase post-surgery; favorable preoperative loading conditions can mask significant myocardial damage

  • Aortic regurgitation: Can tolerate slightly more ventricular dysfunction preoperatively with expectation of functional recovery post-surgery due to afterload reduction; reproducible indexes identify dysfunction earlier 1

Prognostic Considerations

Severe AR is associated with 75% mortality or need for valve replacement within 10 years, with 19% mortality even in asymptomatic severe cases within 6.6 years 6. When combined, moderate AR with moderate MR carries significantly worse prognosis than isolated moderate AR, with increased hazard for death (HR 2.77) and death/heart failure (HR 2.62) 7.

Common Pitfalls

The most critical error is applying the same management principles to both conditions. The normal afterload in MR creates a "honeymoon period" where ejection fraction appears preserved despite significant contractile dysfunction—waiting for symptoms or ventricular dysfunction in MR often means irreversible myocardial damage has occurred. Conversely, the high afterload in AR depresses ejection performance even with preserved contractility, making earlier intervention potentially beneficial with expectation of functional recovery.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.